Testicular cancer: When less is more

Lance C. Pagliaro

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.

Original languageEnglish (US)
Pages (from-to)271-277
Number of pages7
JournalCurrent oncology reports
Volume12
Issue number4
DOIs
StatePublished - Jul 1 2010

Keywords

  • Carboplatin
  • Cisplatin
  • Embryonal carcinoma
  • Male infertility
  • Orchiectomy
  • Radiotherapy
  • Seminoma
  • Teratoma
  • Testicular neoplasm
  • Treatment-related malignancy

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Testicular cancer: When less is more'. Together they form a unique fingerprint.

Cite this